Global Hereditary Angioedema Market Report 2021

Report Description


The Global Hereditary Angioedema Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Hereditary Angioedema Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Hereditary Angioedema Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Hereditary Angioedema Market product affairs. The report is at risk of project regarding this Hereditary Angioedema Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Shire plc
  • CSL Limited
  • Pharming Group NV
  • Ionis Pharmaceuticals, Inc.
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Hereditary Angioedema related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Hereditary Angioedema Market

Hereditary Angioedema Market

Report Highlights:


The Hereditary Angioedema Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Hereditary Angioedema Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Hereditary Angioedema Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Hereditary Angioedema Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Hereditary Angioedema marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Hereditary Angioedema market using a bottom-up approach, wherein manufacturers value data for different type (Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest), , Selective Bradykinin B2 Receptor Antagonist (Firazyr), , Kallikrein Inhibitor (Kalbitor), of Hereditary Angioedema market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Hereditary Angioedema Market

Hereditary Angioedema Market

Key Target Audience:


  • Hereditary Angioedema market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Hereditary Angioedema market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Hereditary Angioedema market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Hereditary Angioedema market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Drug Class - C1 Esterase Inhibitor (Cinryze
  • Berinert
  • and Ruconest)
  • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
  • Kallikrein Inhibitor (Kalbitor

By end-user also classify into, the Global Hereditary Angioedema market:


Global Hereditary Angioedema market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Hospital Pharmacies
  • Retail Pharmacies

Highlights of this 2021-2027 Hereditary Angioedema Market Report:

  • Market dynamics, Hereditary Angioedema economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Hereditary Angioedema industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Hereditary Angioedema Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Hereditary Angioedema businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Hereditary Angioedema market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

Table of Contents

Section 1 Hereditary Angioedema Product Definition

Section 2 Global Hereditary Angioedema Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Hereditary Angioedema Shipments
2.2 Global Manufacturer Hereditary Angioedema Business Revenue
2.3 Global Hereditary Angioedema Market Overview

Section 3 Manufacturer Hereditary Angioedema Business Introduction
3.1 Shire plc Hereditary Angioedema Business Introduction
3.1.1 Shire plc Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
3.1.2 Shire plc Hereditary Angioedema Business Distribution by Region
3.1.3 Shire plc Interview Record
3.1.4 Shire plc Hereditary Angioedema Business Profile
3.1.5 Shire plc Hereditary Angioedema Product Specification

3.2 CSL Limited Hereditary Angioedema Business Introduction
3.2.1 CSL Limited Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
3.2.2 CSL Limited Hereditary Angioedema Business Distribution by Region
3.2.3 Interview Record
3.2.4 CSL Limited Hereditary Angioedema Business Overview
3.2.5 CSL Limited Hereditary Angioedema Product Specification

3.3 Pharming Group NV Hereditary Angioedema Business Introduction
3.3.1 Pharming Group NV Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
3.3.2 Pharming Group NV Hereditary Angioedema Business Distribution by Region
3.3.3 Interview Record
3.3.4 Pharming Group NV Hereditary Angioedema Business Overview
3.3.5 Pharming Group NV Hereditary Angioedema Product Specification

3.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Business Introduction
3.5 iBio Inc. Hereditary Angioedema Business Introduction
3.6 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Business Introduction


Section 4 Global Hereditary Angioedema Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.1.2 Canada Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 South America Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3 Asia Country
4.3.1 China Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3.2 Japan Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3.3 India Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3.4 Korea Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.2 UK Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.3 France Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.4 Italy Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.5 Europe Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.5 Other Country and Region
4.5.1 Middle East Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.5.2 Africa Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.5.3 GCC Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.6 Global Hereditary Angioedema Market Segmentation (Region Level) Analysis 2016-2021
4.7 Global Hereditary Angioedema Market Segmentation (Region Level) Analysis

Section 5 Global Hereditary Angioedema Market Segmentation (Product Type Level)
5.1 Global Hereditary Angioedema Market Segmentation (Product Type Level) Market Size 2016-2021
5.2 Different Hereditary Angioedema Product Type Price 2016-2021
5.3 Global Hereditary Angioedema Market Segmentation (Product Type Level) Analysis

Section 6 Global Hereditary Angioedema Market Segmentation (Industry Level)
6.1 Global Hereditary Angioedema Market Segmentation (Industry Level) Market Size 2016-2021
6.2 Different Industry Price 2016-2021
6.3 Global Hereditary Angioedema Market Segmentation (Industry Level) Analysis

Section 7 Global Hereditary Angioedema Market Segmentation (Channel Level)
7.1 Global Hereditary Angioedema Market Segmentation (Channel Level) Sales Volume and Share 2016-2021
7.2 Global Hereditary Angioedema Market Segmentation (Channel Level) Analysis

Section 8 Hereditary Angioedema Market Forecast 2021-2027
8.1 Hereditary Angioedema Segmentation Market Forecast (Region Level)
8.2 Hereditary Angioedema Segmentation Market Forecast (Product Type Level)
8.3 Hereditary Angioedema Segmentation Market Forecast (Industry Level)
8.4 Hereditary Angioedema Segmentation Market Forecast (Channel Level)

Section 9 Hereditary Angioedema Segmentation Product Type
9.1 Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest) Product Introduction
9.2 , Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Introduction
9.3 , Kallikrein Inhibitor (Kalbitor) Product Introduction

Section 10 Hereditary Angioedema Segmentation Industry
10.1 Hospital Pharmacies Clients
10.2 Retail Pharmacies Clients

Section 11 Hereditary Angioedema Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Chart and Figure
Figure Hereditary Angioedema Product Picture from Shire plc
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Shipments (Units)
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Shipments Share
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Business Revenue Share
Chart Shire plc Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
Chart Shire plc Hereditary Angioedema Business Distribution
Chart Shire plc Interview Record (Partly)
Figure Shire plc Hereditary Angioedema Product Picture
Chart Shire plc Hereditary Angioedema Business Profile
Table Shire plc Hereditary Angioedema Product Specification
Chart CSL Limited Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
Chart CSL Limited Hereditary Angioedema Business Distribution
Chart CSL Limited Interview Record (Partly)
Figure CSL Limited Hereditary Angioedema Product Picture
Chart CSL Limited Hereditary Angioedema Business Overview
Table CSL Limited Hereditary Angioedema Product Specification
Chart Pharming Group NV Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
Chart Pharming Group NV Hereditary Angioedema Business Distribution
Chart Pharming Group NV Interview Record (Partly)
Figure Pharming Group NV Hereditary Angioedema Product Picture
Chart Pharming Group NV Hereditary Angioedema Business Overview
Table Pharming Group NV Hereditary Angioedema Product Specification
3.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Business Introduction

Chart United States Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Canada Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart South America Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart South America Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart China Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Japan Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart India Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Korea Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Germany Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart UK Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart France Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Italy Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Europe Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Europe Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Middle East Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Africa Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart GCC Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart GCC Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Region Level) Sales Volume 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Region Level) Market size 2016-2021
Chart Hereditary Angioedema Market Segmentation (Product Type Level) Volume (Units) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Product Type Level) Market Size (Million $) 2016-2021
Chart Different Hereditary Angioedema Product Type Price ($/Unit) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Industry Level) Market Size (Volume) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Industry Level) Market Size (Share) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Industry Level) Market Size (Value) 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Channel Level) Sales Volume (Units) 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Channel Level) Share 2016-2021
Chart Hereditary Angioedema Segmentation Market Forecast (Region Level) 2021-2027
Chart Hereditary Angioedema Segmentation Market Forecast (Product Type Level) 2021-2027
Chart Hereditary Angioedema Segmentation Market Forecast (Industry Level) 2021-2027
Chart Hereditary Angioedema Segmentation Market Forecast (Channel Level) 2021-2027
Chart Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest) Product Figure
Chart Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest) Product Advantage and Disadvantage Comparison
Chart , Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Figure
Chart , Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Advantage and Disadvantage Comparison
Chart , Kallikrein Inhibitor (Kalbitor) Product Figure
Chart , Kallikrein Inhibitor (Kalbitor) Product Advantage and Disadvantage Comparison
Chart Hospital Pharmacies Clients
Chart Retail Pharmacies Clients

Hereditary Angioedema Market Segments


Hereditary Angioedema Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Drug Class - C1 Esterase Inhibitor (Cinryze
  • Berinert
  • and Ruconest)
  • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
  • Kallikrein Inhibitor (Kalbitor

Hereditary Angioedema Application Outlook (Revenue, USD Million, 2021 2027)


  • Hospital Pharmacies
  • Retail Pharmacies

Hereditary Angioedema Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Europe
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Asia Pacific
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Latin America
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Middle East & Africa
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Hereditary Angioedema Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Hereditary Angioedema Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Hereditary Angioedema Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Hereditary Angioedema Market product affairs. The report is at risk of project regarding this Hereditary Angioedema Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Shire plc
  • CSL Limited
  • Pharming Group NV
  • Ionis Pharmaceuticals, Inc.
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Hereditary Angioedema related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Hereditary Angioedema Market

Hereditary Angioedema Market

Report Highlights:


The Hereditary Angioedema Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Hereditary Angioedema Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Hereditary Angioedema Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Hereditary Angioedema Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Hereditary Angioedema marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Hereditary Angioedema market using a bottom-up approach, wherein manufacturers value data for different type (Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest), , Selective Bradykinin B2 Receptor Antagonist (Firazyr), , Kallikrein Inhibitor (Kalbitor), of Hereditary Angioedema market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Hereditary Angioedema Market

Hereditary Angioedema Market

Key Target Audience:


  • Hereditary Angioedema market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Hereditary Angioedema market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Hereditary Angioedema market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Hereditary Angioedema market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Drug Class - C1 Esterase Inhibitor (Cinryze
  • Berinert
  • and Ruconest)
  • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
  • Kallikrein Inhibitor (Kalbitor

By end-user also classify into, the Global Hereditary Angioedema market:


Global Hereditary Angioedema market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Hospital Pharmacies
  • Retail Pharmacies

Highlights of this 2021-2027 Hereditary Angioedema Market Report:

  • Market dynamics, Hereditary Angioedema economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Hereditary Angioedema industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Hereditary Angioedema Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Hereditary Angioedema businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Hereditary Angioedema market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
Table of Contents

Section 1 Hereditary Angioedema Product Definition

Section 2 Global Hereditary Angioedema Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Hereditary Angioedema Shipments
2.2 Global Manufacturer Hereditary Angioedema Business Revenue
2.3 Global Hereditary Angioedema Market Overview

Section 3 Manufacturer Hereditary Angioedema Business Introduction
3.1 Shire plc Hereditary Angioedema Business Introduction
3.1.1 Shire plc Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
3.1.2 Shire plc Hereditary Angioedema Business Distribution by Region
3.1.3 Shire plc Interview Record
3.1.4 Shire plc Hereditary Angioedema Business Profile
3.1.5 Shire plc Hereditary Angioedema Product Specification

3.2 CSL Limited Hereditary Angioedema Business Introduction
3.2.1 CSL Limited Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
3.2.2 CSL Limited Hereditary Angioedema Business Distribution by Region
3.2.3 Interview Record
3.2.4 CSL Limited Hereditary Angioedema Business Overview
3.2.5 CSL Limited Hereditary Angioedema Product Specification

3.3 Pharming Group NV Hereditary Angioedema Business Introduction
3.3.1 Pharming Group NV Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
3.3.2 Pharming Group NV Hereditary Angioedema Business Distribution by Region
3.3.3 Interview Record
3.3.4 Pharming Group NV Hereditary Angioedema Business Overview
3.3.5 Pharming Group NV Hereditary Angioedema Product Specification

3.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Business Introduction
3.5 iBio Inc. Hereditary Angioedema Business Introduction
3.6 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Business Introduction


Section 4 Global Hereditary Angioedema Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.1.2 Canada Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 South America Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3 Asia Country
4.3.1 China Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3.2 Japan Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3.3 India Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.3.4 Korea Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.2 UK Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.3 France Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.4 Italy Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.4.5 Europe Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.5 Other Country and Region
4.5.1 Middle East Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.5.2 Africa Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.5.3 GCC Hereditary Angioedema Market Size and Price Analysis 2016-2021
4.6 Global Hereditary Angioedema Market Segmentation (Region Level) Analysis 2016-2021
4.7 Global Hereditary Angioedema Market Segmentation (Region Level) Analysis

Section 5 Global Hereditary Angioedema Market Segmentation (Product Type Level)
5.1 Global Hereditary Angioedema Market Segmentation (Product Type Level) Market Size 2016-2021
5.2 Different Hereditary Angioedema Product Type Price 2016-2021
5.3 Global Hereditary Angioedema Market Segmentation (Product Type Level) Analysis

Section 6 Global Hereditary Angioedema Market Segmentation (Industry Level)
6.1 Global Hereditary Angioedema Market Segmentation (Industry Level) Market Size 2016-2021
6.2 Different Industry Price 2016-2021
6.3 Global Hereditary Angioedema Market Segmentation (Industry Level) Analysis

Section 7 Global Hereditary Angioedema Market Segmentation (Channel Level)
7.1 Global Hereditary Angioedema Market Segmentation (Channel Level) Sales Volume and Share 2016-2021
7.2 Global Hereditary Angioedema Market Segmentation (Channel Level) Analysis

Section 8 Hereditary Angioedema Market Forecast 2021-2027
8.1 Hereditary Angioedema Segmentation Market Forecast (Region Level)
8.2 Hereditary Angioedema Segmentation Market Forecast (Product Type Level)
8.3 Hereditary Angioedema Segmentation Market Forecast (Industry Level)
8.4 Hereditary Angioedema Segmentation Market Forecast (Channel Level)

Section 9 Hereditary Angioedema Segmentation Product Type
9.1 Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest) Product Introduction
9.2 , Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Introduction
9.3 , Kallikrein Inhibitor (Kalbitor) Product Introduction

Section 10 Hereditary Angioedema Segmentation Industry
10.1 Hospital Pharmacies Clients
10.2 Retail Pharmacies Clients

Section 11 Hereditary Angioedema Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Hereditary Angioedema Market Segments


Hereditary Angioedema Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Drug Class - C1 Esterase Inhibitor (Cinryze
  • Berinert
  • and Ruconest)
  • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
  • Kallikrein Inhibitor (Kalbitor

Hereditary Angioedema Application Outlook (Revenue, USD Million, 2021 2027)


  • Hospital Pharmacies
  • Retail Pharmacies

Hereditary Angioedema Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Europe
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Asia Pacific
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Latin America
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

  • Middle East & Africa
    • Hereditary Angioedema market, By Product Type Outlook
      • Drug Class - C1 Esterase Inhibitor (Cinryze
      • Berinert
      • and Ruconest)
      • Selective Bradykinin B2 Receptor Antagonist (Firazyr)
      • Kallikrein Inhibitor (Kalbitor

    • Hereditary Angioedema market, By Application Outlook
      • Hospital Pharmacies
      • Retail Pharmacies

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
Chart and Figure
Figure Hereditary Angioedema Product Picture from Shire plc
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Shipments (Units)
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Shipments Share
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Hereditary Angioedema Business Revenue Share
Chart Shire plc Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
Chart Shire plc Hereditary Angioedema Business Distribution
Chart Shire plc Interview Record (Partly)
Figure Shire plc Hereditary Angioedema Product Picture
Chart Shire plc Hereditary Angioedema Business Profile
Table Shire plc Hereditary Angioedema Product Specification
Chart CSL Limited Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
Chart CSL Limited Hereditary Angioedema Business Distribution
Chart CSL Limited Interview Record (Partly)
Figure CSL Limited Hereditary Angioedema Product Picture
Chart CSL Limited Hereditary Angioedema Business Overview
Table CSL Limited Hereditary Angioedema Product Specification
Chart Pharming Group NV Hereditary Angioedema Shipments, Price, Revenue and Gross profit 2016-2021
Chart Pharming Group NV Hereditary Angioedema Business Distribution
Chart Pharming Group NV Interview Record (Partly)
Figure Pharming Group NV Hereditary Angioedema Product Picture
Chart Pharming Group NV Hereditary Angioedema Business Overview
Table Pharming Group NV Hereditary Angioedema Product Specification
3.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Business Introduction

Chart United States Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Canada Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart South America Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart South America Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart China Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Japan Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart India Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Korea Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Germany Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart UK Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart France Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Italy Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Europe Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Europe Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Middle East Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Africa Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart GCC Hereditary Angioedema Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart GCC Hereditary Angioedema Sales Price ($/Unit) 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Region Level) Sales Volume 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Region Level) Market size 2016-2021
Chart Hereditary Angioedema Market Segmentation (Product Type Level) Volume (Units) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Product Type Level) Market Size (Million $) 2016-2021
Chart Different Hereditary Angioedema Product Type Price ($/Unit) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Industry Level) Market Size (Volume) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Industry Level) Market Size (Share) 2016-2021
Chart Hereditary Angioedema Market Segmentation (Industry Level) Market Size (Value) 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Channel Level) Sales Volume (Units) 2016-2021
Chart Global Hereditary Angioedema Market Segmentation (Channel Level) Share 2016-2021
Chart Hereditary Angioedema Segmentation Market Forecast (Region Level) 2021-2027
Chart Hereditary Angioedema Segmentation Market Forecast (Product Type Level) 2021-2027
Chart Hereditary Angioedema Segmentation Market Forecast (Industry Level) 2021-2027
Chart Hereditary Angioedema Segmentation Market Forecast (Channel Level) 2021-2027
Chart Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest) Product Figure
Chart Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest) Product Advantage and Disadvantage Comparison
Chart , Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Figure
Chart , Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Advantage and Disadvantage Comparison
Chart , Kallikrein Inhibitor (Kalbitor) Product Figure
Chart , Kallikrein Inhibitor (Kalbitor) Product Advantage and Disadvantage Comparison
Chart Hospital Pharmacies Clients
Chart Retail Pharmacies Clients
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Soprano Mandolin Market

Report Description The Global Soprano Mandolin Market Report provides Insightful information to the

Read More

Soprano Ukuleles Market

Key Industry Insights This report is an extensive study that includes a detailed overview of the Sop

Read More

Tennis Rackets Market

Report Description The Global Tennis Rackets Market Report provides Insightful information to the cl

Read More